PHIBRO ANIMAL HEALTH CORP-A (PAHC) Forecast, Price Target & Analyst Ratings

NASDAQ:PAHC • US71742Q1067

Current stock price

54.53 USD
+0.56 (+1.04%)
Last:

Analyst forecast overview

View the latest analyst price targets, stock forecast, EPS estimates, revenue projections, revisions, full estimates, rating distribution and upgrades/downgrades for PHIBRO ANIMAL HEALTH CORP-A (PAHC).

Forecast Snapshot

Consensus Price Target

Price Target
$46.24
-15.20% Downside
→ Price target details

Next Earnings Forecast

Earnings Estimate
Release Date
May 13, 2026
Period
Q3 / 2026
EPS Estimate
$0.73
Revenue Estimate
372.51M
→ Full earnings forecast details

ChartMill Buy Consensus

Rating
48.89%
Weighted Analyst Rating Score
→ Analyst Ratings details

Price Target Details & History

Consensus Price Target and Range

Mean target
$46.24
Upside
-15.20%
From current price of $54.53 to mean target of $46.24, Based on 9 analyst forecasts
Low
$38.38
Median
$49.98
High
$51.45

Price Target Revisions

1 Month
0.00%
3 Months
5.43%

Price Target Summary

9 Wall Street analysts provided a forecast for the next 12 months for PAHC. The average price target is 46.24 USD. This implies a price decrease of -15.2% is expected in the next year compared to the current price of 54.53.
The average price target has been revised upward by 5.43% in the past 3 months.
→ Find peer stocks trading 30% below analyst price target

Analyst Ratings & History

Current Analyst Ratings

PAHC Current Analyst RatingPAHC Current Analyst Buy, Sell and Hold Ratings.Current Analyst Rating Strong Buy Buy Hold Sell Strong Sell 0 0 0 0 0

Analyst Ratings History

PAHC Historical Analyst RatingsPAHC Historical Analyst Buy, Sell and Hold Ratings and number of analysts.Historical Monthly Analyst Rating -19 -17 -15 -13 -11 -9 -7 -5 -3 -1 2 4 6 8

Analyst Ratings Consensus

ChartMill Buy Consensus
48.89%
PAHC was analyzed by 9 analysts. The buy percentage consensus is at 49. So analysts seem to be rather neutral about PAHC.
In the previous month the buy percentage consensus was at a similar level.
PAHC was analyzed by 9 analysts. More opinions would make the average more meaningful.
→ Find peer stocks with a buy consensus above 85%

Recent Upgrades & Downgrades

DateFirmActionFrom → To
2026-04-15CitigroupInitiate Neutral
2025-11-07JP MorganMaintains Overweight -> Overweight
2025-08-29B of A SecuritiesMaintains Underperform -> Underperform
2025-07-07JP MorganUpgrade Neutral -> Overweight
2025-06-25Morgan StanleyMaintains Equal-Weight -> Equal-Weight
2025-05-08Morgan StanleyMaintains Equal-Weight -> Equal-Weight
2025-02-10BarclaysMaintains Underweight -> Underweight
2024-12-17Morgan StanleyMaintains Equal-Weight -> Equal-Weight
2024-11-12BarclaysMaintains Underweight -> Underweight
2024-09-10JP MorganInitiate Neutral
2024-08-30B of A SecuritiesMaintains Underperform -> Underperform
2024-05-10BarclaysMaintains Underweight -> Underweight
2023-11-09Morgan StanleyMaintains Equal-Weight -> Equal-Weight
2023-09-01Roth MKMReiterate Buy -> Buy
2023-08-31Morgan StanleyMaintains Equal-Weight -> Equal-Weight
2023-08-29Roth MKMReiterate Buy -> Buy
2023-07-27Morgan StanleyReiterate Equal-Weight -> Equal-Weight
2023-05-04Morgan StanleyMaintains Equal-Weight
2023-02-09Morgan StanleyMaintains Equal-Weight
2022-12-21Roth CapitalInitiate Buy
2022-11-10Morgan StanleyMaintains Equal-Weight
2022-09-16BarclaysMaintains Underweight
2022-08-26Morgan StanleyMaintains Equal-Weight
2022-07-25BarclaysDowngrade Equal-Weight -> Underweight
2022-01-10BarclaysUpgrade Underweight -> Equal-Weight

Next Earnings Forecast Details

Next Earnings Details

Release Date
May 13, 2026
Period
Q3 / 2026
EPS Estimate
$0.73
Revenue Estimate
372.51M
Revenue Q2Q
7.10%
EPS Q2Q
15.36%
Number of Analysts
6

Next Earnings Revisions

Revenue (1 Month)
0.00%
Revenue (3 Months)
0.34%
EPS (1 Month)
0.00%
EPS (3 Months)
4.78%

Next Earnings Summary

PAHC is expected to report earnings on 5/13/2026. The consensus EPS estimate for the next earnings is 0.73 USD and the consensus revenue estimate is 372.51M USD.
The next earnings revenue estimate has been revised upward by 0.34% in the past 3 months.
→ Find peers expecting at least 20% revenue growth next quarter

Full Analyst Estimates 2026 - 2029

Yearly Earnings Per Share (EPS), Revenue, EBIT, EBITDA and Operating Margin Analyst Estimates

2023 2024 2025 2026 2027 2028 2029
Revenue
YoY % growth
PAHC revenue by date.PAHC revenue by date.
977.9M
3.78%		1.018B
4.07%		1.296B
27.37%		1.517B
17.03%		1.575B
3.82%		1.625B
3.17%		1.181B
-27.32%
EBITDA
YoY % growth
PAHC ebitda by date.PAHC ebitda by date.
105.81M
-5.28%		110.762M
4.68%		182.967M
65.19%		255.39M
39.58%		273.31M
7.02%		289M
5.74%		148.92M
-48.47%
EBIT
YoY % growth
PAHC ebit by date.PAHC ebit by date.
71.8M
-9.11%		74.584M
3.88%		137.362M
84.17%		207.16M
50.81%		221.69M
7.01%		238.5M
7.58%		120.36M
-49.53%
Operating Margin
PAHC operating margin by date.PAHC operating margin by date.
7.34%7.33%10.60%13.66%14.08%14.68%10.19%
EPS
YoY % growth
PAHC eps by date.PAHC eps by date.
1.22
0.83%		1.19
-2.46%		2.09
75.63%		3.09
47.63%		3.43
11.24%		3.78
10.15%		N/A

All data in USD

Quarterly Earnings Per Share (EPS), Revenue, EBIT and EBITDA Analyst Estimates

Q3 / 26 Q4 / 26 Q1 / 27 Q2 / 27 Q3 / 27 Q4 / 27
EPS
Q2Q % growth		0.73
15.36%		0.73
27.95%		0.83
13.18%		0.95
9.03%		0.79
8.07%		0.70
-3.50%
Revenue
Q2Q % growth		372.51M
7.10%		396.64M
4.74%		N/AN/AN/AN/A
EBITDA
Q2Q % growth		58.351M
-22.49%		57.579M
-30.61%		N/AN/AN/AN/A
EBIT
Q2Q % growth		50.964M
21.08%		50.261M
34.47%		N/AN/AN/AN/A

All data in USD

Yearly Earnings Per Share (EPS) and Revenue Trends vs Historical Data

PAHC Yearly Revenue VS EstimatesPAHC Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 500M 1B 1.5B
PAHC Yearly EPS VS EstimatesPAHC Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 1 2 3

Long Term Forward Growth Forecast Summary

Long Term EPS Growth (CAGR)

EPS Next 3 Year
21.85%
EPS Next 5 Year
N/A

Long Term Revenue Growth (CAGR)

Revenue Next 3 Year
7.61%
Revenue Next 5 Year
-2.45%

Long Term EBIT Growth (CAGR)

EBIT Next 3 Year
28.38%
EBIT Next 5 Year
2.18%
→ Find peers expecting at least 20% CAGR revenue growth over the next 3 years

PHIBRO ANIMAL HEALTH CORP-A / PAHC Forecast FAQ

Can you provide the average price target for PHIBRO ANIMAL HEALTH CORP-A stock?

9 analysts have analysed PAHC and the average price target is 46.24 USD. This implies a price decrease of -15.2% is expected in the next year compared to the current price of 54.53.

What is the next earnings date for PAHC stock?

PHIBRO ANIMAL HEALTH CORP-A (PAHC) will report earnings on 2026-05-13.

What are the consensus estimates for PHIBRO ANIMAL HEALTH CORP-A (PAHC) next earnings?

The consensus EPS estimate for the next earnings of PHIBRO ANIMAL HEALTH CORP-A (PAHC) is 0.73 USD and the consensus revenue estimate is 372.51M USD.

What is the expected long term growth rate for PHIBRO ANIMAL HEALTH CORP-A (PAHC)?

The expected long term growth rate for PHIBRO ANIMAL HEALTH CORP-A (PAHC) is 7.61%.